Crossmark Global Holdings, Inc. Catalent, Inc. Transaction History
Crossmark Global Holdings, Inc.
- $5.22 Billion
- Q1 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 9,067 shares of CTLT stock, worth $514,370. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,067
Previous 9,359
3.12%
Holding current value
$514,370
Previous $421,000
21.62%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding CTLT
# of Institutions
485Shares Held
172MCall Options Held
865KPut Options Held
687K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$862 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA12.9MShares$733 Million0.12% of portfolio
-
Nomura Holdings Inc Tokyo, M011.3MShares$639 Million1.65% of portfolio
-
Janus Henderson Group PLC London, X09.56MShares$542 Million0.3% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.2B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...